dc.contributor.author | Kjerpeseth, Lars Jøran | |
dc.contributor.author | Ellekjær, Hanne | |
dc.contributor.author | Selmer, Randi | |
dc.contributor.author | Ariansen, Inger Kristine | |
dc.contributor.author | Furu, Kari | |
dc.contributor.author | Skovlund, Eva | |
dc.date.accessioned | 2018-08-07T10:48:49Z | |
dc.date.available | 2018-08-07T10:48:49Z | |
dc.date.created | 2017-08-10T11:02:26Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | European Journal of Clinical Pharmacology. 2017, . | |
dc.identifier.issn | 0031-6970 | |
dc.identifier.uri | http://hdl.handle.net/11250/2507752 | |
dc.language.iso | eng | |
dc.title | Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015 | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.description.version | acceptedVersion | |
dc.source.pagenumber | 9 | |
dc.source.journal | European Journal of Clinical Pharmacology | |
dc.identifier.doi | 10.1007/s00228-017-2296-1 | |
dc.identifier.cristin | 1485327 | |
cristin.unitcode | 7502,3,9,0 | |
cristin.unitcode | 7502,3,8,0 | |
cristin.unitname | Legemiddelepidemiologi | |
cristin.unitname | Ikke-smittsomme sykdommer | |
cristin.ispublished | false | |
cristin.fulltext | postprint | |
cristin.qualitycode | 2 | |